Differential Expression of Ubiquitin-Specific Protease 16 Gene by Methylprednisolone in Neuronal Cells

  • Choi, Seung-Won (Departments of Neurosurgery, Chungnam National University School of Medicine) ;
  • Kwon, Hyon-Jo (Departments of Neurosurgery, Chungnam National University School of Medicine) ;
  • Koh, Hyeon-Song (Departments of Neurosurgery, Chungnam National University School of Medicine) ;
  • Song, Shi-Hun (Departments of Neurosurgery, Chungnam National University School of Medicine) ;
  • Kwon, O-Yu (Departments of Anatomy, Chungnam National University School of Medicine) ;
  • Kim, Seon-Hwan (Departments of Neurosurgery, Chungnam National University School of Medicine)
  • ;
  • ;
  • ;
  • ;
  • ;
  • 김성환 (충남대학교병원 신경외과학)
  • Received : 2010.05.31
  • Accepted : 2010.06.23
  • Published : 2010.06.30

Abstract

Methylprednisolone (MPD) is a synthetic glucocorticoid drug used in treatment of many neurological diseases and neurotraumas, including spinal cord injuries. Little is known of the mechanism of MPD in neuronal cells, particularly the genetic expression aspect. DD-PCR was used in identification of genes expressed during MPD treatment of PC12 cells. We have isolated 3 predicted up- or down-regulated genes, which are differentially expressed in neurons by MPD. One of these genes, USP16 (ubiquitin specific protease 16), is the deubiquitinating enzyme that is up-regulated by MPD in neurons. In order to observe the effect of MPD on USP16 gene expression, PC12 cells were treated under several experimental conditions, including endoplasmic reticulum stress drugs. We have isolated the total RNAs in PC12 cells and detected USP16 and ER related genes by RT-PCR. Because its expression pattern is similar to expression of ER chaperons, USP16 gene expression is strongly associated with unfolded protein response. A meaningful negative effect on each tissue treated by methylprednisolone is not shown in vivo. USP16 gene expression is suppressed by LY294002 (phosphatidylinositol 3-kinase inhibitor), which suggests that USP16 gene expression is regulated by the phosphatidylinositol 3-kinase pathway.

Keywords

References

  1. Amerik AY, Hochstrasser M. Mechanism and function of deubiquitinating enzymes. Biochim Biophys Acta. 2004. 1695: 189-207. https://doi.org/10.1016/j.bbamcr.2004.10.003
  2. Anderson DC, Cranford RE. Glucocorticoids in ischemic stroke. Stroke 1979. 10: 68-71. https://doi.org/10.1161/01.STR.10.1.68
  3. Baek KH. Conjugation and deconjugation of ubiquitin regulating the destiny of proteins. Exp Mol Med. 2003. 35: 1-7. https://doi.org/10.1038/emm.2003.1
  4. Bukau B, Weissman J, Horwich A. Molecular chaperones and protein quality control. Cell 2006. 125: 443-451. https://doi.org/10.1016/j.cell.2006.04.014
  5. Cai SY, Babbitt RW, Marchesi VT. A mutant deubiquitinating enzyme (Ubp-M) associates with mitotic chromosomes and blocks cell division. Proc Natl Acad Sci USA. 1999. 96: 2828-2833. https://doi.org/10.1073/pnas.96.6.2828
  6. Chyatte D, Fode NC, Nichols DA, Sundt TM Jr. Preliminary report: Effects of high dose methylprednisolone on delayed cerebral ischemia in patients at high risk for vasospasm after aneurysmal subarachnoid hemorrhage. Neurosurgery 1987. 21. 157-160. https://doi.org/10.1227/00006123-198708000-00004
  7. Craig MA, Beppler GA, Santos C, Raffa RB. A second (nongenomic) steroid mechanism of action: possible opportunity for novel pharmacotherapy? J Clin Pharm Ther. 2005. 30: 305-312. https://doi.org/10.1111/j.1365-2710.2005.00664.x
  8. Eck JC, Nachtigall D, Humphreys SC, Hodges SD. Questionnaire survey of spine surgeons on the use of methylprednisolone for acute spinal cord injury. Spine 2006. 31: E250-E253. https://doi.org/10.1097/01.brs.0000214886.21265.8c
  9. Gomes JA, Stevens RD, Lewin JJ 3rd, Mirski MA, Bhardwaj A. Glucocorticoid therapy in neurologic critical care. Crit Care Med. 2005. 33: 1214-1224. https://doi.org/10.1097/01.CCM.0000166389.85273.38
  10. Graner E, Tang D, Rossi S, Baron A, Migita T, Weinstein LJ, Lechpammer M, Huesken D, Zimmermann J, Signoretti S, Loda M. The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer. Cancer Cell 2004. 5: 253-261. https://doi.org/10.1016/S1535-6108(04)00055-8
  11. Hall ED. The neuroprotective pharmacology of methylprednisolone. J Neurosurg. 1992. 76: 13-22. https://doi.org/10.3171/jns.1992.76.1.0013
  12. Harding HP, Ron D. Endoplasmic reticulum stress and the development of diabetes: Diabetes 2002. 51 Suppl 3: S455 -S461. https://doi.org/10.2337/diabetes.51.2007.S455
  13. Nishikawa S, Brodsky JL, Nakatsukasa K. Roles of molecular chaperones in endoplasmic reticulum (ER) quality control and ER-associated degradation (ERAD). J Biochem (Tokyo). 2005. 137: 551-555. https://doi.org/10.1093/jb/mvi068
  14. Puente XS, Sanchez LM, Overall CM, Lopez-Otin C. Human and mouse proteases: a comparative genomic approach. Nat Rev Genet. 2003. 4: 544-558. https://doi.org/10.1038/nrg1111
  15. Sayer FT, Kronvall E, Nilsson OG. Methylprednisolone treatment in acute spinal cord injury: the myth challenged through a structured analysis of published literature. Spine J. 2006. 6: 335-343. https://doi.org/10.1016/j.spinee.2005.11.001
  16. Schroder M, Kaufman RJ. ER stress and the unfolded protein response. Mutat Res. 2005. 569: 29-63. https://doi.org/10.1016/j.mrfmmm.2004.06.056
  17. Schroder M, Kaufman RJ. Divergent roles of IRE1alpha and PERK in the unfolded protein response. Curr Mol Med. 2006. 6: 5-36. https://doi.org/10.2174/156652406775574569
  18. Sinha S, Bastin ME, Wardlaw JM, Armitage PA, Whittle IR. Effects of dexamethasone on peritumoural oedematous brain: A DT-MRI study. J Neurol Neurosurg Psychiatry 2004. 75: 1632-1635. https://doi.org/10.1136/jnnp.2003.028647
  19. Sulea T, Lindner HA, Menard R. Structural aspects of recently discovered viral deubiquitinating activities. Biol Chem. 2006. 387: 853-862. https://doi.org/10.1515/BC.2006.108
  20. van Laar T, van der Eb AJ, Terleth C. Mif1: a missing link between the unfolded protein response pathway and ER-associated protein degradation? Curr Protein Pept Sci. 2001. 2: 169-190. https://doi.org/10.2174/1389203013381189